|
1）Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004; 350: 2050-9
|
|
|
|
2）Park EJ, Cho MS, Baek SJ, et al. Long-term Oncologic Outcomes of Robotic Low Anterior Resection for Rectal Cancer: A Comparative Study With Laparoscopic Surgery. Ann Surg. 2014 Mar 21. [Epub ahead of print]
|
|
|
|
|
|
3）Kim JY, Kim NK, Lee KY, et al. A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol. 2012; 19: 2485-93
|
|
|
|
|
|
4）Ikematsu H, Yoda Y, Matsuda T, et al. Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology. 2013; 144: 551-9
|
|
|
|
|
|
5）Saraste D, Gunnarsson U, Janson M. Local excision in early rectal cancer-outcome worse than expected: a population based study. Eur J Surg Oncol. 2013; 39: 634-9
|
|
|
|
|
|
6）Saraste D, Gunnarsson U, Janson M. Predicting lymph node metastases in early rectal cancer. Eur J Cancer. 2013; 49: 1104-8
|
|
|
|
|
|
7）Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010; 11: 835-44
|
|
|
|
|
|
8）Garcia-Aguilar J, Smith DD, Avila K, et al. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg. 2011; 254: 97-102
|
|
|
|
|
|
9）Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012; 99: 918-28
|
|
|
|
|
|
10）Habr-Gama A, Perez RO, Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006; 10: 1319-28
|
|
|
|
|
|
11）Park IJ, You YN, Skibber JM, et al. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2013; 56: 135-41
|
|
|
|
|
|
12）Mignanelli ED, de Campos-Lobato LF, Stocchi L, et al. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Dis Colon Rectum. 2010; 53: 251-6
|
|
|
|
|
|
13）Mezhir JJ, Shia J, Riedel E, et al. Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome. Ann Surg. 2012; 256: 274-9
|
|
|
|
|
|
14）Park IJ, Yu CS. Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy. World J Gastroenterol. 20148; 20: 2023-9
|
|
|
|
|
|
15）Das P, Skibber JM, Rodriguez-Bigas MA, et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006; 29: 219-24
|
|
|
|
|
|
16）Hofheinz RD, Wenz F, Post S, et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol. 2012; 13: 579-88
|
|
|
|
|
|
17）Rodel C, Liersch T, Becker H, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012; 13: 679-87
|
|
|
|
|
|
18）Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 2012; 13: 616-21
|
|
|
|
|